يعرض 1 - 10 نتائج من 19 نتيجة بحث عن '"Julie E Davidson"', وقت الاستعلام: 1.48s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris-Saclay, GlaxoSmithKline, Glaxo Smith Kline, University of Cambridge [UK] (CAM), Universiteit Gent = Ghent University [Belgium] (UGENT), Leiden University Medical Center (LUMC), Karolinska Institutet [Stockholm], Karolinska University Hospital [Stockholm], Hôpital Lapeyronie [Montpellier] (CHU), Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Unité de recherche Phytopharmacie et Médiateurs Chimiques (UPMC), Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service de rhumatologie [CHU Pitié Salpêtrière] (GRC-08 EEMOIS), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Innsbruck Medical University [Austria] (IMU), Sanofi Aventis R&D [Chilly-Mazarin], Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS - UM 4 (UMR 8258 / U1022)), Institut de Chimie du CNRS (INC)-Université de Paris (UP)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Sorbonne Paris Cité (USPC), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital Paul Brousse, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse, CHU Sainte Justine [Montréal], Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Rhumatologie [CHU Pitié Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPC), Universiteit Gent = Ghent University (UGENT), Universiteit Leiden, Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Graduate School, 01 Internal and external specialisms, AII - Inflammatory diseases, Clinical Immunology and Rheumatology, Experimental Immunology, Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière] (I3), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)

    المصدر: Seminars in Arthritis and Rheumatism
    Seminars in Arthritis and Rheumatism, WB Saunders, 2019, 48 (6), pp.967-975. ⟨10.1016/j.semarthrit.2018.10.006⟩
    Seminars in Arthritis and Rheumatism, 2019, 48 (6), pp.967-975. ⟨10.1016/j.semarthrit.2018.10.006⟩
    Seminars in arthritis and rheumatism, 48(6), 967-975. W.B. Saunders Ltd
    Seminars in Arthritis and Rheumatism, 48(6), 967-975

  4. 4
  5. 5
  6. 6

    المساهمون: Institut Català de la Salut, [Link J] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. [Ramanujam R] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. KTH - Royal Institute of Technology, Stockholm, Sweden. [Auer M] Innsbruck Medical University, Innsbruck, Austria. [Ryner M] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. [Hässler S, Bachelet D] CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France. [Fissolo N, Comabella M, Montalban X] Centre d'Esclerosi Múltiple de Catalunya, Barcelona, Spain. Hospital Universitari Vall d'Hebron, Barcelona, Spain., Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus

    المصدر: PLoS ONE, Vol 12, Iss 2, p e0170395 (2017)
    Scientia
    Recercat. Dipósit de la Recerca de Catalunya
    instname
    Link, J, Ramanujam, R, Auer, M, Ryner, M, Hässler, S, Bachelet, D, Mbogning, C, Warnke, C, Buck, D, Hyldgaard Jensen, P E, Sievers, C, Ingenhoven, K, Fissolo, N, Lindberg, R, Grummel, V, Donnellan, N, Comabella, M, Montalban, X, Kieseier, B, Soelberg Sørensen, P, Hartung, H-P, Derfuss, T, Lawton, A, Sikkema, D, Pallardy, M, Hemmer, B, Deisenhammer, F, Broët, P, Dönnes, P, Davidson, J, Fogdell-Hahn, A & ABIRISK Consortium 2017, ' Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe : A descriptive study of test results ', PLOS ONE, vol. 12, no. 2, e0170395 . https://doi.org/10.1371/journal.pone.0170395
    Recercat: Dipósit de la Recerca de Catalunya
    Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
    PLoS ONE

    مصطلحات موضوعية: Male, 0301 basic medicine, Time Factors, Physiology, Denmark, lcsh:Medicine, Esclerosi múltiple, Biochemistry, Geographical Locations, 0302 clinical medicine, Natalizumab, Immune Physiology, Medicine and Health Sciences, Otros calificadores::Otros calificadores::/inmunología [Otros calificadores], Young adult, Child, lcsh:Science, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados::natalizumab [COMPUESTOS QUÍMICOS Y DROGAS], media_common, Aged, 80 and over, Immune System Proteins, Multidisciplinary, Pharmaceutics, Age Factors, Natalizumab/adverse effects, Antígens - Immunologia, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], Neurodegenerative Diseases, Middle Aged, Interferó - Immunologia, 3. Good health, Test (assessment), Europe, Neurology, Austria, Child, Preschool, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Female, localizaciones geográficas::Europa (continente) [DENOMINACIONES GEOGRÁFICAS], Research Article, medicine.drug, Adult, Drug, medicine.medical_specialty, Multiple Sclerosis, Adolescent, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized::Natalizumab [CHEMICALS AND DRUGS], media_common.quotation_subject, Immunology, MEDLINE, Geographic Locations::Europe [GEOGRAPHICALS], Antibodies, Autoimmune Diseases, Interferon-beta/adverse effects, Young Adult, 03 medical and health sciences, Sex Factors, Pharmacotherapy, Drug Therapy, Immunologic Factors/adverse effects, Other subheadings::Other subheadings::/immunology [Other subheadings], Internal medicine, medicine, Immunologic Factors, Humans, Antibodies/immunology, Antigens, Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Cytokines::Interferons::Interferon Type I::Interferon-beta [CHEMICALS AND DRUGS], Aged, Retrospective Studies, Pharmacology, Sweden, Drug Screening, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies [CHEMICALS AND DRUGS], aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos [COMPUESTOS QUÍMICOS Y DROGAS], Multiple sclerosis, lcsh:R, Infant, Newborn, Biology and Life Sciences, Proteins, Infant, nutritional and metabolic diseases, Retrospective cohort study, Interferon-beta, medicine.disease, Demyelinating Disorders, 030104 developmental biology, People and Places, Multiple Sclerosis/drug therapy, Clinical Immunology, lcsh:Q, Interferons, Clinical Medicine, aminoácidos, péptidos y proteínas::péptidos::péptidos y proteínas de señalización intercelular::citocinas::interferones::interferón de tipo I::interferón beta [COMPUESTOS QUÍMICOS Y DROGAS], 030217 neurology & neurosurgery

    وصف الملف: application/pdf

  7. 7

    المصدر: Bachelet, D, Hässler, S, Mbogning, C, Link, J, Ryner, M, Ramanujam, R, Auer, M, Jensen, P E H, Koch-Henriksen, N, Warnke, C, Ingenhoven, K, Buck, D, Grummel, V, Lawton, A, Donnellan, N, Hincelin-Mery, A, Sikkema, D, Pallardy, M, Kieseier, B, Hemmer, B, Hartung, H P, Soelberg Sorensen, P, Deisenhammer, F, Dönnes, P, Davidson, J, Fogdell-Hahn, A, Broët, P & ABIRISK Consortium 2016, ' Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis : A Collaborative Cohort Analysis ', P L o S One, vol. 11, no. 11, e0162752, pp. 1-19 . https://doi.org/10.1371/journal.pone.0162752
    PLoS ONE, Vol 11, Iss 11, p e0162752 (2016)
    PLoS ONE

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10

    المصدر: Sleep, vol 38, iss 7

    وصف الملف: application/pdf